Cover image not available

Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia : systematic reviews and economic analyses

T. G. Pavey

Publication Data

Title Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia : systematic reviews and economic analyses
Author T. G. Pavey
Contributors NIHR Evaluation, Trials and Studies Coordinating Centre, NIHR Health Technology Assessment Programme
Publisher Prepress Projects Ltd
Publication date 0000
Publication location Perth, Scotland

Topics

Chronic myeloid leukemia :: Chemotherapy
Imatinib :: Testing
Clinical trials :: Great Britain
Medical economics :: Great Britain

Catalogue Data

OBNB ID GBB316438
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.994190610724

ISBD

P1053 xx, 277 pages
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia : systematic reviews and economic analyses by T. G. Pavey. Published by Prepress Projects Ltd. Publication and catalogue information, links to buy online and reader comments.